Enanta Pharmaceuticals Inc (ENTA)
9.21
-0.10
(-1.07%)
USD |
NASDAQ |
Nov 22, 10:20
Enanta Pharmaceuticals Total Assets (Quarterly): 398.82M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 398.82M |
| March 31, 2024 | 413.56M |
| December 31, 2023 | 428.50M |
| September 30, 2023 | 462.28M |
| June 30, 2023 | 495.17M |
| March 31, 2023 | 326.44M |
| December 31, 2022 | 347.53M |
| September 30, 2022 | 375.41M |
| June 30, 2022 | 385.21M |
| March 31, 2022 | 406.82M |
| December 31, 2021 | 440.59M |
| September 30, 2021 | 438.79M |
| June 30, 2021 | 450.44M |
| March 31, 2021 | 467.77M |
| December 31, 2020 | 481.01M |
| September 30, 2020 | 486.13M |
| June 30, 2020 | 511.70M |
| March 31, 2020 | 513.50M |
| December 31, 2019 | 510.97M |
| September 30, 2019 | 489.83M |
| June 30, 2019 | 473.48M |
| March 31, 2019 | 461.58M |
| December 31, 2018 | 454.22M |
| September 30, 2018 | 414.23M |
| June 30, 2018 | 379.08M |
| Date | Value |
|---|---|
| March 31, 2018 | 354.65M |
| December 31, 2017 | 340.72M |
| September 30, 2017 | 326.64M |
| June 30, 2017 | 275.84M |
| March 31, 2017 | 278.96M |
| December 31, 2016 | 278.38M |
| September 30, 2016 | 281.28M |
| June 30, 2016 | 281.93M |
| March 31, 2016 | 281.60M |
| December 31, 2015 | 278.38M |
| September 30, 2015 | 246.01M |
| June 30, 2015 | 237.77M |
| March 31, 2015 | 245.88M |
| December 31, 2014 | 215.43M |
| September 30, 2014 | 155.42M |
| June 30, 2014 | 159.51M |
| March 31, 2014 | 108.35M |
| December 31, 2013 | 110.16M |
| September 30, 2013 | 116.97M |
| June 30, 2013 | 119.67M |
| March 31, 2013 | 125.63M |
| December 31, 2012 | 72.48M |
| September 30, 2012 | 52.16M |
| June 30, 2012 | 54.33M |
| September 30, 2011 | 26.10M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
326.44M
Minimum
Mar 2023
513.50M
Maximum
Mar 2020
438.98M
Average
440.59M
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
| iBio Inc | 24.52M |
| Theriva Biologics Inc | 40.11M |
| Oragenics Inc | 5.204M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 249.91M |
| Shareholders Equity (Quarterly) | 148.92M |
| Current Ratio | 4.922 |